Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCohi-O Lens in Immune-related Ocular Surface Diseases
NCT07902687Phase 1Not yet recruiting
- Sponsor
- Guangdong ProCapZoom Biosciences Co., Ltd.
- Start
- Nov 2026
- Primary completion
- Nov 2028
01
Overview
Phase 1, open-label, single-arm trial in ocular surface disease (OSD), sponsored by Guangdong ProCapZoom Biosciences Co., Ltd. Primary endpoint: Incidence and severity of adverse events at 29 days. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
ocular surface disease (OSD)
Beyond the preview
Go deeper on NCT07902687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07902687.